There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.
Jennifer N. Clements, PharmD, BCPS, CDE
Advertisement
Articles by Jennifer N. Clements, PharmD, BCPS, CDE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Stanford, Harvard, and Yale Are Betting on Psychedelics
2
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
3
Comprehensive Lancet Review Reaffirms Safety, Effectiveness of mRNA Vaccines
4
NIH Expands All of Us Dataset to Advance Precision Medicine Across Diverse Population
5